Two-thirds of our business is repeat business, coming from scientists we have worked with before. (2019/20)

“Thank you very much for the reliable and professional collaboration. It was a pleasure working with Gifford. Further collaboration using rat spinal chord sections are, therefore, definitely an option.” Preclinical Research Manager, German Pharma, Jan...

“If I haven’t told you before – you are all truly wonderful. Thank you sincerely for your ongoing support and collaboration.” VP of Drug Development, Australian Biotech, Nov 2019

An international customer base: 54% of our clients are from the USA, 26% from Europe, 20% from Asia/Pacific. (2019/20)

“KD determination of drug binding to targets, by equilibrium and kinetic measurements, is an essential component of our mechanism of action analyses for drug development. Gifford Bioscience performs this service using radionuclides with the highest quality, in a...